Metastasiertes Prostatakarzinom: Positionspapier zum Einsatz der Chemotherapie = Metastasized prostate cancer : position paper on the use of chemotherapy
Background Antihormonal and cytotoxic therapy options are available for the therapy of metastasized prostate cancer (mPC). Because no comparative studies are available, especially for castration-resistant prostate cancer (mCRCP), it remains unclear which patients will profit best from which therapy....
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Deutsch Englisch |
| Veröffentlicht: |
July 2015
|
| In: |
Der Urologe
Year: 2015, Jahrgang: 54, Heft: 7, Pages: 998-1001 |
| DOI: | 10.1007/s00120-015-3841-0 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s00120-015-3841-0 Verlag, Volltext: https://link.springer.com/article/10.1007/s00120-015-3841-0 
|
| Verfasserangaben: | C.-H. Ohlmann, S. Duensing, R. Eichenauer, F. König, S. Machtens, M. Schostak, C. Thomas, P. Albers |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1556038496 | ||
| 003 | DE-627 | ||
| 005 | 20221117134808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170329s2015 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00120-015-3841-0 |2 doi | |
| 035 | |a (DE-627)1556038496 | ||
| 035 | |a (DE-576)486038491 | ||
| 035 | |a (DE-599)BSZ486038491 | ||
| 035 | |a (OCoLC)1340969081 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a ger |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ohlmann, Carsten-Henning |e VerfasserIn |0 (DE-588)1022541129 |0 (DE-627)716997908 |0 (DE-576)361868138 |4 aut | |
| 245 | 1 | 0 | |a Metastasiertes Prostatakarzinom |b Positionspapier zum Einsatz der Chemotherapie = Metastasized prostate cancer : position paper on the use of chemotherapy |c C.-H. Ohlmann, S. Duensing, R. Eichenauer, F. König, S. Machtens, M. Schostak, C. Thomas, P. Albers |
| 246 | 3 | 1 | |a Metastasized prostate cancer |b position paper on the use of chemotherapy |
| 264 | 1 | |c July 2015 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.03.2017 | ||
| 520 | |a Background Antihormonal and cytotoxic therapy options are available for the therapy of metastasized prostate cancer (mPC). Because no comparative studies are available, especially for castration-resistant prostate cancer (mCRCP), it remains unclear which patients will profit best from which therapy.Objectives Previous data on the sequence of the various therapy options show that correct selection of the first line therapy for mCRPC can have an influence on the prognosis of the patient. In this position paper the various therapy options are critically illustrated and the clinical and pathohistological criteria for selection of the first line therapy of mCRPC are discussed.Results Molecular markers are an important aid for future patient selection and individualized therapy for optimal use of the available forms of therapy. | ||
| 700 | 1 | |a Duensing, Stefan |d 1967- |e VerfasserIn |0 (DE-588)1074044487 |0 (DE-627)830213007 |0 (DE-576)435550098 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Der Urologe |d [Berlin : Springer Medizin, 2005 |g 54(2015), 7, Seite 998-1001 |h Online-Ressource |w (DE-627)101704192X |w (DE-600)2925337-8 |w (DE-576)501620842 |7 nnas |a Metastasiertes Prostatakarzinom Positionspapier zum Einsatz der Chemotherapie = Metastasized prostate cancer : position paper on the use of chemotherapy |
| 773 | 1 | 8 | |g volume:54 |g year:2015 |g number:7 |g pages:998-1001 |g extent:4 |a Metastasiertes Prostatakarzinom Positionspapier zum Einsatz der Chemotherapie = Metastasized prostate cancer : position paper on the use of chemotherapy |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00120-015-3841-0 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00120-015-3841-0 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170329 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1074044487 |a Duensing, Stefan |m 1074044487:Duensing, Stefan |d 910000 |d 910200 |e 910000PD1074044487 |e 910200PD1074044487 |k 0/910000/ |k 1/910000/910200/ |p 2 | ||
| 999 | |a KXP-PPN1556038496 |e 2962923011 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["ger","eng"],"recId":"1556038496","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 29.03.2017"],"titleTranslated":[{"translated":"Metastasized prostate cancer"}],"person":[{"display":"Ohlmann, Carsten-Henning","roleDisplay":"VerfasserIn","role":"aut","family":"Ohlmann","given":"Carsten-Henning"},{"family":"Duensing","given":"Stefan","display":"Duensing, Stefan","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Metastasiertes Prostatakarzinom","subtitle":"Positionspapier zum Einsatz der Chemotherapie = Metastasized prostate cancer : position paper on the use of chemotherapy","title_sort":"Metastasiertes Prostatakarzinom"}],"relHost":[{"pubHistory":["Volume 44, issue 7 (July 2005)-volume 61, issue 5 (May 2022)"],"part":{"extent":"4","volume":"54","text":"54(2015), 7, Seite 998-1001","pages":"998-1001","issue":"7","year":"2015"},"disp":"Metastasiertes Prostatakarzinom Positionspapier zum Einsatz der Chemotherapie = Metastasized prostate cancer : position paper on the use of chemotherapyDer Urologe","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 05.07.2022"],"recId":"101704192X","language":["ger"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"Deutsche Gesellschaft für Urologie","role":"isb"}],"title":[{"title_sort":"Urologe","title":"Der Urologe"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"[Berlin ; Heidelberg ; New York]","publisher":"Springer Medizin","dateIssuedDisp":"[2005-2022]"}],"id":{"zdb":["2925337-8"],"eki":["101704192X"]},"name":{"displayForm":["Deutsche Gesellschaft für Urologie"]}}],"physDesc":[{"extent":"4 S."}],"name":{"displayForm":["C.-H. Ohlmann, S. Duensing, R. Eichenauer, F. König, S. Machtens, M. Schostak, C. Thomas, P. Albers"]},"id":{"doi":["10.1007/s00120-015-3841-0"],"eki":["1556038496"]},"origin":[{"dateIssuedDisp":"July 2015","dateIssuedKey":"2015"}]} | ||
| SRT | |a OHLMANNCARMETASTASIE2015 | ||